The effects of folate supplementation on some coagulation parameters and oxidative status surrogates

European Journal of Clinical Pharmacology

Volumn 58, Issue 1, 2002, Pages 1-5

  Mayer, Otto ^a   Šimon, Jaroslav ^a   Rosolová, Hana ^a   Hromádka, Milan ^b   Šubrt, Ivan ^b   Vobrubová, Ivana ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Coagulation; Folate; Homocysteine

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN III; FIBRINOGEN; FOLIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; MALONALDEHYDE; PLASMINOGEN; SUPEROXIDE DISMUTASE; VON WILLEBRAND FACTOR;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CONTROLLED STUDY; CORONARY RISK; DRUG EFFECT; ENDOTHELIUM LESION; FEMALE; FLUORESCENCE; GENETIC POLYMORPHISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUPPLEMENTATION;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; FEMALE; FOLIC ACID; HEMATINICS; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDATIVE STRESS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 0036217512     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-001-0421-6     Document Type: Article

References (29)

1. Plasma homocysteine as a risk factor for vascular disease
2. The effect of homocysteine on the coronary risk
3. Homocysteine, a risk factor for cardiovascular disease
4. The oxidant stress of hyperhomocyst(e)inemia
5. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans
6. Vitamin intake: A possible determinant on plasma homocysteine among middle aged adults
7. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention
8. Folic acid prevents nitroglycerine-induced nitric oxide synthase dysfunction and nitrate tolerance
9. Homocysteine and coronary artery disease
10. Statistics for health workers (in Czech)
11. The influence of folate supplementation on coagulation factors in mild hyperhomocysteinemia
12. Plasma homocystein and cardiovascular disease
13. Activation of endogenous factor V by homocysteine induced vascular cell activator
14. Activation of Hageman factor by L-homocysteine
15. Homocysteine, factor VII and antithrombin III in subjects with different gene dosage for cystathion-β synthase
16. Lowering blood homocysteine with folic acid based supplements meta-analysis of randomised trials
17. Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation
18. Endothelial cell injury due to copper-catalysed hydrogen-peroxide generation from homocysteine
19. Oxidation of low density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor
20. Increased lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits
21. Protein and lipid oxidation of banked human erythrocytes: Role of glutathione
22. Influence of folic acid on postprandial endothelial dysfunction
23. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo controlled trial
24. Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
25. Three months supplementation of hyperhomocysteinaemic patients with folic acid and vitamin B6 improves biological markers of endothelial dysfunction
26. Effect of short-term vitamin administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia
27. Sick individuals and sick populations
28. Oxidative stress and cardiovascular disease
29. What level of plasma homocysteine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocysteine levels above and below 14 μmol/l